These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6305848)

  • 1. Cefotaxime and desacetyl cefotaxime in human bile.
    Kees F; Strehl E; Dominiak P; Grobecker H; Seeger K; Seidel G; Neuhaus B; Safrany L
    Infection; 1983; 11(2):118-20. PubMed ID: 6305848
    [No Abstract]   [Full Text] [Related]  

  • 2. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.
    Limbert M; Seibert G; Schrinner E
    Infection; 1982; 10(2):97-100. PubMed ID: 6284653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of human bile and serum levels by high pressure liquid chromatography after administration of latamoxef or cefotaxime.
    Krausse R; Ullmann U; Brandstetter G; Kratochvil P
    Arzneimittelforschung; 1984; 34(12):1787-91. PubMed ID: 6099130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatography.
    Kees F; Strehl E; Seeger K; Seidel G; Dominiak P; Grobecker H
    Arzneimittelforschung; 1981; 31(2):362-5. PubMed ID: 6261772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefmenoxime].
    Shimizu K
    Jpn J Antibiot; 1983 Jun; 36(6):1165-72. PubMed ID: 6317903
    [No Abstract]   [Full Text] [Related]  

  • 6. Penetration of cefotaxime into respiratory secretions.
    Fick RB; Alexander MR; Prince RA; Kasik JE
    Antimicrob Agents Chemother; 1987 May; 31(5):815-7. PubMed ID: 3606080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone: renal and biliary excretion and effect on the colon microflora.
    Arvidsson A; Alván G; Angelin B; Borgå O; Nord CE
    J Antimicrob Chemother; 1982 Sep; 10(3):207-15. PubMed ID: 6292158
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biliary excretion of cefotaxime and desacetylcefotaxime].
    Jehl F; Peter JD; Picard A; Dupeyron JP; Marescaux J; Sibilly A; Monteil H
    Rev Med Interne; 1987; 8(5):487-92. PubMed ID: 3445030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotaxime: sites and pathway of metabolic conversion.
    Macdonald CM; McDonald A; Fromson JM; Coombes JD
    Arzneimittelforschung; 1984; 34(12):1729-35. PubMed ID: 6099127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
    Matzke GR; Abraham PA; Halstenson CE; Keane WF
    Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cefotaxime versus desacetyl cefotaxime on human neutrophil functions.
    Labro M; Bryskier A
    Chemioterapia; 1987 Jun; 6(2 Suppl):237-9. PubMed ID: 3334564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effects of cefotiam in biliary tract infections].
    Ozawa K; Nakagawa H; Sato O; Maekawa T; Wagai K; Kidokoro T
    Jpn J Antibiot; 1982 May; 35(5):1163-6. PubMed ID: 6290700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic killing of gram-negative bacilli by cefotaxime, its desacetyl metabolite and human polymorphonuclear neutrophils.
    Mandell LA; Afnan M
    J Antimicrob Chemother; 1991 Jun; 27(6):817-28. PubMed ID: 1938688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
    Marone P; Navarra A; Monzillo V; Traverso A
    Drugs Exp Clin Res; 1990; 16(12):629-33. PubMed ID: 2130005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis.
    Dalmau D; Layrargues GP; Fenyves D; Willems B; Turgeon F; Turgeon P
    J Infect Dis; 1999 Nov; 180(5):1597-602. PubMed ID: 10515821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of beta-lactamases on desacetyl-cefotaxime and cefotaxime.
    Labia R; Morand A; Kazmierczak A
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():45-51. PubMed ID: 6094462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in neonates.
    Crooks J; White LO; Burville LJ; Speidel BD; Reeves DS
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():97-101. PubMed ID: 6094467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.